Original Article
Author Details :
Volume : 8, Issue : 1, Year : 2022
Article Page : 21-27
https://doi.org/10.18231/j.ijced.2022.005
Abstract
Background: Keloid is deregulated fibroproliferative growth in response to tissue injury. Keloids are known for their stubborn nature and present as therapeutic challenges in practice. Aim of our study is to evaluate various treatment modalities for search of treatment which stand out with maximum efficacy and least side effect.
Materials and Methods: 120 patients with presternal keloid (female and male, aged 18-60 years) were recruited to receive one of the five treatment methods which were(1) Cryotherapy,(2) Cryotherapy and intralesional Triamcinolone acetonide,(3) Cryotherapy and intralesional 5- Fluorouracil(4) Cryotherapy and combination of Intralesional Triamcinolone acetonide with 5- Fluorouracil(5) Cryotherapy and Intralesional Triamcinolone acetonide combined with Silicone gel sheet application in each group respectively. Evaluation done by the Patient and Observer Scar Assessment Scale (POSAS) score at every 3 week till 6 months.
Results: Patients with significant improvement (> 50% reduction in POSAS) were 42%, 75%, 75%, 85%, and 90% in each 5 group respectively. Side effects like Hypopigmentation and Skin atrophy were significantly much frequent in group 2 while skin ulceration and pain were common with group 3. Group 1 showed maximum recurrence of lesion while no recurrence was seen in group-2 and 5 even after 3 month of post treatment.
Conclusion: Among nonsurgical treatment modalities, Cryotherapy along with intralesional medication like triamcinolone acetonide and 5 fluorouracil and adjuvant therapy like silicone gel sheet are promising, inexpensive and an effective OPD based treatment that provide good alternative for keloid treatment in comparison to surgical procedures.
Keywords: Cryotherapy, 5 Fluorouracil, Keloid, Silicon gel sheet, Triamcinolone acetonide
How to cite : Gamit H H, Karia U K, Shah B J, Therapeutic evaluation of various modalities in keloid. IP Indian J Clin Exp Dermatol 2022;8(1):21-27
This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
Received : 02-01-2022
Accepted : 20-01-2022
Viewed: 1035
PDF Downloaded: 378